$390 Million is the total value of Anson Funds Management LP's 68 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COLD | AMERICOLD RLTY TR | $2,741,000 | +6.7% | 75,500 | 0.0% | 0.70% | -33.4% | |
| AMT | AMERICAN TOWER CORP NEW | $1,655,000 | +18.7% | 6,400 | 0.0% | 0.42% | -25.8% | |
| ABBV | ABBVIE INC | $1,473,000 | +28.9% | 15,000 | 0.0% | 0.38% | -19.4% | |
| ARE | ALEXANDRIA REAL ESTATE EQ IN | $974,000 | +18.5% | 6,000 | 0.0% | 0.25% | -26.0% | |
| KMI | KINDER MORGAN INC DEL | $692,000 | +9.0% | 45,600 | 0.0% | 0.18% | -32.2% | |
| MDGSW | MEDIGUS LTD*w exp 07/23/202 | $36,000 | +71.4% | 21,000 | 0.0% | 0.01% | 0.0% | |
| KZIA | KAZIA THERAPEUTICS LTDsponsored adr | $0 | – | 550,000 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 27 | Q3 2023 | 8.7% |
| BK OF AMERICA CORP | 25 | Q1 2024 | 15.9% |
| GRANITE REAL ESTATE INVT TR | 18 | Q2 2024 | 1.3% |
| JPMORGAN CHASE & CO | 17 | Q2 2022 | 2.2% |
| MEDIGUS LTD | 17 | Q1 2023 | 0.0% |
| TC ENERGY CORP | 16 | Q2 2024 | 0.6% |
| Americas Gold & Silver Corp | 16 | Q2 2024 | 0.6% |
| SPDR S&P 500 ETF Trust | 15 | Q2 2024 | 57.0% |
| WISDOMTREE TR | 15 | Q2 2018 | 4.0% |
| RANDGOLD RES LTD | 15 | Q2 2018 | 3.3% |
View Anson Funds Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| View, Inc. | April 05, 2024 | 441,703 | 9.9% |
| 22nd Century Group, Inc. | February 14, 2024 | 3,178,491 | 7.3% |
| BIOLASE, INC | February 14, 2024 | 185,127 | 8.1% |
| Greenwave Technology Solutions, Inc. | February 14, 2024 | 1,249,200 | 7.5% |
| INPIXON | February 14, 2024 | 19,338,936 | 9.9% |
| ISUN, INC. | February 14, 2024 | 3,500,000 | 9.3% |
| Nova Lifestyle, Inc. | February 14, 2024 | 74,300 | 4.4% |
| Spero Therapeutics, Inc. | February 14, 2024 | 4,297,599 | 8.1% |
| Trilogy International Partners Inc. | February 14, 2024 | 8,980,250 | 10.1% |
| ZyVersa Therapeutics, Inc. | February 14, 2024 | 160,671 | 9.8% |
View Anson Funds Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-13 |
| SC 13D | 2024-07-09 |
| 13F-HR | 2024-05-14 |
| SC 13D/A | 2024-04-05 |
| DFAN14A | 2024-04-04 |
| 4 | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Anson Funds Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.